Skip to main content
Equibles

Man Group plc

Position in PBYI — Puma Biotechnology, Inc.

CIK 1637460 LONDON, X0
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$336,613
+$33,887 QoQ
Shares Held
41,506
-12.4% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 160 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. PBYI ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5
397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in PBYI

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $336,613 41,506
2026-03-31 $302,726 47,375
2025-12-31 $281,577 47,324
2025-03-31 $110,908 37,469
2024-06-30 $383,587 117,665
2024-03-31 $1,121,914 211,682
2023-12-31 $730,513 168,710
2023-03-31 $192,996 62,458
2022-12-31 $201,978 47,749
2022-09-30 $47,828 20,181
2022-06-30 $55,000 19,166
2022-03-31 $232,706 80,801
2021-12-31 $169,939 55,901
2021-09-30 $155,622 22,200
2020-09-30 $344,412 34,134
2020-06-30 $420,683 40,334
2020-03-31 $288,090 34,134